Abstract:AIM:To examine the effect of celecoxib on tumor growth and angiogenesis in an orthotopic implantation tumor model of colon cancer.METHODS:Human colorectal adenocarcinoma HT-29 cells were implanted subcutaneously in nude mice. Four groups of animals received different doses of celecoxib after tumor implantation. After 42 days, all animals were evaluated for changes in body weight, the volume and weight of colorectal tumors, and tumor growth inhibition. The content of prostaglandin E(2) (PGE(2)) in the tumor tissue homogenate was estimated by radioimmunoassay (RIA). Cyclooxygenase-2 (COX-2) and CD34 expression in tumor tissue was assessed by immunohistochemistry, and the microvessel density (MVD) of tumor tissue was determined. Apoptosis of the tumor cells was detected by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL). The expression of vascular endothelial growth factor (VEGF) mRNA and matrix metalloproteinase-2 (MMP-2) mRNA extracted from the tumor tissue was analyzed by reverse transcriptase polymerase chain reaction (RT-PCR).RESULTS:There was no statistically significant change in the animals' body weight between the treatment groups. However, with increasing doses of celecoxib, the volume and weight of the tumor decreased. The rates of tumor growth inhibition for the L (low), M (medium) and H (high) groups were 25.30%, 38.80%, and 76.92%, respectively, which were significant compared to the C (control) group. There were significant differences in COX-2 expression in the tumor tissue between all groups, except between the L and M groups. Celecoxib exposure also reduced PGE2 levels in the tumor tissue homogenates. The level of PGE(2) correlated to the weight of tumor (r=0.8814, P < 0.05) and to COX-2 expression (r=0.8249, Puse < 0.05). Compared to the control group, the tumor cells from celecoxib-treated mice had a significantly higher apoptotic index. Celecoxib also decreased CD34(+) expression in tumors from treated mice. There were significant differences in the MVD between all groups except between groups H and M. Celecoxib significantly reduced the expression of VEGF and MMP-2 mRNA in the group H but not in L and M groups. The MVD in tumor tissue was closely related to the PGE2 levels, as well as the expression of VEGF and MMP-2 mRNA (r = 0.9006, r = 0.8573 and r = 0.6427, respectively; P < 0.05).CONCLUSIONS:By inhibiting COX-2, PGE(2) synthesis, and VEGF and MMP-2 mRNA expression in tumor tissue, celecoxib enhances tumor cell apoptosis, thereby inhibiting the growth and angiogenesis of orthotopically implanted tumors in a mouse model of human colorectal cancer.

Effect of Inhibiting Cyclooxygenase-2 Expression on Glioma Immune Microenvironment and Biological Behavior

[Effect of Selective Cyclooxygenase-2 Inhibitor Celebrex on Expression of Vascular Endothelial Growth Factor (VEGF) in Pancreatic Carcinoma].

Impact of the Selective Cyclooxygenase-2 Inhibitor Celebrex on Angiogenesis in Pancreatic Carcinoma

Effect of Celecoxib on Proliferation, Moving and Invasiveness of Glioma Cells

Cyclooxygenase-2 Induces Angiogenesis in Pancreatic Cancer Mediated by Prostaglandin E-2

Effects of cyclooxygenase-2 inhibitor on proliferation and apoptosis of C6 glioma cells

The effect of COX-2 inhibitor on bladder cancer

Effect of Celecoxib on Growth and Angiogenesis of Orthotopic Transplantation Tumor of Experimental Colorectal Cancer

Effect of Cyclooxygenase-2 Inhibitor on CD4+ CD25+ Regulatory T Cells in Mouse Hepatocellular Carcinoma

Celecoxib Inhibits Tumor Growth and Angiogenesis in an Orthotopic Implantation Tumor Model of Human Colon Cancer.

Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum

Experimental study on inhibitive effect of celecoxib on lung cancer

Celecoxib Alleviates Radiation-Induced Brain Injury in Rats by Maintaining the Integrity of Blood-Brain Barrier

Experimental Study on Inhibitive Effect of a Non-Steroidal Anti-Inflammatory Drug,celecoxib,on Lung Adenocarcinoma

Antitumor Effects of Specific Cyclooxygenase-2 Inhibitors Combined with Chemotherapeutic Agents on Glioma Cells in Vitro

Therapeutic Effects of COX-2 Inhibitor Celecoxib on Nude Mice Bearing Human Pancreatic Cancer Xenograft

Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity.

Effect Of Celecoxib Combined With Chemotherapy Drug On Malignant Biological Behaviors Of Gastric Cancer

Inhibitory Effect of a Non-Steroidal Anti-Inflammatory Drug,celecoxib,on Angiogenesis in Lung Cancer

THE INHIBITORY EFFECT OF CELECOXIB ON LUNG CANCER CELL LINE IN VITRO

Inhibitory Effects of Cyclooxygenase-2 Inhibitor and Α-Interferon on Growth of Human Liver Cancer Xenografts and Tumor Angiogenesis in Nude Mice